Cytori Therapeutics raised a round of funding on August 14, 2006.
Cytori Therapeutics, formerly MacroPore, is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. The c…